Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Silgan Holdings
SLGN
$4.51B
| $3.58M | ﹤0.01% |
83,650
+7,649
| +10% | +$316K |
|
1152
NVR
NVR
$17.1B
| $3.57M | ﹤0.01% |
605
+14
| +2% | +$73.9K |
|
|
SC
1153
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $3.57M | ﹤0.01% |
85,003
+252
| +0.3% | +$10.6K |
|
1154
Rogers Communications
RCI
$18.8B
| $3.55M | ﹤0.01% |
74,542
| – | – |
|
1155
Corcept Therapeutics
CORT
$9.98B
| $3.5M | ﹤0.01% |
176,591
+15,249
| +9% | +$309K |
|
1156
AGNC Investment
AGNC
$12.7B
| $3.48M | ﹤0.01% |
231,084
-275,164
| -54% | -$4.36M |
|
1157
Kimco Realty
KIM
$17.5B
| $3.46M | ﹤0.01% |
140,183
+55,423
| +65% | +$1.28M |
|
1158
AES
AES
$10.6B
| $3.45M | ﹤0.01% |
141,835
-12,723
| -8% | -$309K |
|
1159
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
| $3.44M | ﹤0.01% |
56,195
+425
| +0.8% | +$26.3K |
|
1160
Tencent Music
TME
$15.9B
| $3.38M | ﹤0.01% |
493,622
-205,803
| -29% | -$1.52M |
|
1161
Insperity
NSP
$2.03B
| $3.31M | ﹤0.01% |
28,058
+3,240
| +13% | +$383K |
|
1162
Boston Properties
BXP
$11.6B
| $3.28M | ﹤0.01% |
28,497
-146
| -0.5% | -$16.8K |
|
1163
Sutro Biopharma
STRO
$386M
| $3.28M | ﹤0.01% |
22,005
+324
| +1% | +$58K |
|
1164
Celanese
CE
$4.82B
| $3.26M | ﹤0.01% |
19,394
-104,462
| -84% | -$17M |
|
1165
Royal Caribbean
RCL
$86.5B
| $3.26M | ﹤0.01% |
42,395
+1,029
| +2% | +$83.6K |
|
1166
Incyte
INCY
$25.8B
| $3.21M | ﹤0.01% |
43,674
+4,770
| +12% | +$322K |
|
|
FBC
1167
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.19M | ﹤0.01% |
66,530
+16,856
| +34% | +$836K |
|
1168
RH
RH
$3.33B
| $3.16M | ﹤0.01% |
5,906
+1,709
| +41% | +$1.05M |
|
|
IMGN
1169
DELISTED
Immunogen Inc
IMGN
| $3.14M | ﹤0.01% |
423,863
+404,198
| +2,055% | +$2.51M |
|
1170
Quanta Services
PWR
$84.2B
| $3.12M | ﹤0.01% |
27,220
+13,692
| +101% | +$1.58M |
|
1171
Ultragenyx Pharmaceutical
RARE
$2.46B
| $3.09M | ﹤0.01% |
36,688
-61,841
| -63% | -$5.03M |
|
1172
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $3.04M | ﹤0.01% |
47,704
+18,384
| +63% | +$1.15M |
|
1173
Huntington Ingalls Industries
HII
$11B
| $3.04M | ﹤0.01% |
16,261
-136,457
| -89% | -$26.4M |
|
1174
Arch Capital
ACGL
$35.7B
| $3.01M | ﹤0.01% |
67,748
-9,672
| -12% | -$410K |
|
1175
Teladoc Health
TDOC
$1.66B
| $2.99M | ﹤0.01% |
32,577
+2,415
| +8% | +$289K |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.